Dysmenorrhea Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

Trends, opportunity and forecast in dysmenorrhea treatment market to 2030 by treatment type (non-steroidal anti-inflammatory drugs and hormonal therapy), type (primary dysmenorrhea and secondary dysmenorrhea), end use (hospitals & clinics and research center), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Published	Pages	Publisher	Report code
Jan 2024	150	Lucintel	ASDR-665591

Published: Jan 2024 - Pages : 150 - Publisher : Lucintel - Report code : ASDR-665591

• Novartis
• Bayer
• Abbott Laboratories
• F. Hoffmann-La Roche
• Sanofi
• Pfizer
• GlaxoSmithKline